Cancer-Critical Genes I: Proto-oncogenes
Implicit Differentiation
Logarithmic Differentiation
Cellular Differentiation
Differential Leveling
Integrator and Differentiator
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 14, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Tina L Yuan1, Arnaud Amzallag2, Rachel Bagni3
1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1450 3rd Street, San Francisco, CA 94158, USA.
This study reveals distinct KRAS effector dependencies in cancer cell lines. Identifying two subtypes of KRAS-mutant cancers offers new therapeutic strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: